Leishmania donovani mevalonate kinase regulates host actin for inducing phagocytosis

Tanvir Bamra1, Taj Shafi1, Sushmita Das2

  • 1Department of Molecular Biology, ICMR- Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, 800 007, India.

Biochimie
|December 20, 2023
PubMed

Insights

Leishmania donovani uses Mevalonate kinase (MVK) to enter host macrophages, manipulating actin and signaling pathways for survival. Antibodies targeting LdMVK show potential for treating leishmaniasis.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Macrophages are key in Leishmania infection, but parasite-driven invasion mechanisms are unclear.
  • Understanding host-pathogen interactions is crucial for developing anti-Leishmania strategies.

Purpose of the Study:

  • To elucidate the role of Leishmania donovani Mevalonate kinase (LdMVK) in parasite entry and host cell manipulation.
  • To investigate LdMVK's impact on actin reorganization, signaling pathways, and macrophage functions.

Main Methods:

  • Analysis of LdMVK's interaction with host cell machinery.
  • Investigating modulation of actin-related proteins (VASP, Src, ERM).
  • Assessing effects on calcium (Ca2+) signaling and the Akt pathway.

Main Results:

  • LdMVK enters the macrophage cytosol, inducing actin assembly modulation via VASP, Src, and ERM activation.
  • LdMVK triggers Ca2+ signaling and Akt pathway activation in macrophages.
  • Antibodies against LdMVK induce extracellular trap formation, killing infected macrophages.

Conclusions:

  • LdMVK is a virulence factor mediating Leishmania internalization and host cell modulation.
  • LdMVK targets host protein phosphorylation and calcium homeostasis, impacting disease progression.
  • LdMVK presents a potential target for therapeutic intervention against leishmaniasis.